Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts
- Conditions
- Trophic UlcerNon-healing WoundNon-Healing Ulcer of Skin
- Interventions
- Biological: Dermal fibroblastsDevice: LED phototherapy
- Registration Number
- NCT04483934
- Brief Summary
Treatment of patients with non-healing wounds and trophic ulcers using local LED phototherapy with local transplantation of autologous dermal fibroblasts
- Detailed Description
During the implementation of the project, it was planned to develop a method for the treatment of trophic ulcers using injection of autologous dermal fibroblasts in the wound.
The positive outlook for the effectiveness of photodiode therapy with dermal fibroblasts is due to the following:
* the ability of fibroblasts to stimulate tissue regeneration
* positive results of preclinical studies of the method of treatment of long-term non-healing wounds in animals (rats).
Twelve patients were included in the study. Dermal fibroblasts were isolated from the skin patients, cultured and then transplanted back to the wound.
The therapeutic dose of cells was 50k per cm2 of the wound area. Follow up patients monitoring was performed at 1, 2 and more months after injection.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- Trophic Ulcers
- Chronic non-healing wounds
- acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis
- mental disorders
- pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Patients treated with dermal fibroblasts LED phototherapy Cultured dermal fibroblasts and LED phototherepy Patients treated with dermal fibroblasts Dermal fibroblasts Cultured dermal fibroblasts and LED phototherepy
- Primary Outcome Measures
Name Time Method Number of patients with tropic ulcers cured 1 month Number of patients cured
Number of patients with treatment-related adverse events 4 weeks Fibroblasts injection related adverse events assessed by blood count and function tests
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
🇧🇾Minsk, Belarus